Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
1,323.47
1,194.65
1,220.83
1,119.74
1,190.39
1,153.67
1,166.93
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,323.47
1,194.65
1,220.83
1,119.74
1,190.39
1,153.67
1,166.93
Raw Material Cost
408.88
459.71
429.76
260.58
269.73
476.58
409.15
Purchase of Finished goods
127.45
71.38
41.80
120.91
231.60
133.77
173.04
(Increase) / Decrease In Stocks
-0.08
-68.14
43.71
62.79
-2.36
-130.23
-31.16
Employee Cost
247.11
229.54
226.78
225.52
222.86
215.64
215.70
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
-0.01
0.00
0.00
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
300.40
266.22
247.23
231.86
250.70
247.60
215.61
Total Expenditure (Excl Depreciation)
1,083.76
958.70
989.27
901.66
972.53
943.36
982.33
Operating Profit (PBDIT) excl Other Income
239.71
235.95
231.56
218.08
217.86
210.31
184.60
Other Income
8.13
106.86
27.14
8.58
11.98
5.62
28.41
Operating Profit (PBDIT)
247.84
342.81
258.70
226.66
229.84
215.93
213.01
Interest
41.58
43.38
46.13
47.46
50.32
52.18
73.82
Exceptional Items
-6.41
-3.30
-8.77
-8.37
-27.42
-2.43
-3.87
Gross Profit (PBDT)
199.85
296.13
203.80
170.83
152.10
161.32
135.32
Depreciation
53.25
50.62
49.64
48.89
48.86
48.42
48.45
Profit Before Tax
148.05
245.48
153.12
122.04
106.38
113.85
86.21
Tax
18.77
37.35
21.59
16.45
20.76
23.81
13.94
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
127.83
208.15
132.57
105.49
82.49
89.09
72.93
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
127.83
208.15
132.57
105.49
82.49
89.09
72.93
Share in Profit of Associates
1.45
-0.03
-1.05
0.10
3.13
0.95
-0.66
Minority Interest
2.34
6.02
3.99
5.99
3.42
2.09
0.43
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
126.94
202.11
127.53
99.61
82.19
87.95
71.84
Equity Capital
92.17
92.17
92.17
92.16
92.16
92.16
91.96
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
13.77
21.93
13.84
10.81
8.92
9.54
3.42
Diluted Earnings per share
13.77
21.92
13.84
10.81
8.92
9.55
3.42
Operating Profit Margin (Excl OI)
18.11%
19.75%
18.97%
19.48%
18.3%
18.23%
15.82%
Gross Profit Margin
15.1%
24.79%
16.69%
15.26%
12.78%
13.98%
11.6%
PAT Margin
9.77%
17.42%
10.77%
9.43%
7.19%
7.8%
6.19%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 11.18% vs 14.08% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 54.45% vs 352.09% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 10.03% vs 6.63% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -17.37% vs -29.23% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
Compare Quarterly Results Of Strides Pharma With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
1,323.47
353.09
970.38
274.83%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,323.47
353.09
970.38
274.83%
Raw Material Cost
408.88
27.73
381.15
1,374.50%
Purchase of Finished goods
127.45
46.34
81.11
175.03%
(Increase) / Decrease In Stocks
-0.08
-7.83
7.75
98.98%
Employee Cost
247.11
106.63
140.48
131.75%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
300.40
118.20
182.20
154.15%
Total Expenditure (Excl Depreciation)
1,083.76
291.07
792.69
272.34%
Operating Profit (PBDIT) excl Other Income
239.71
62.02
177.69
286.50%
Other Income
8.13
4.11
4.02
97.81%
Operating Profit (PBDIT)
247.84
66.13
181.71
274.78%
Interest
41.58
1.38
40.20
2,913.04%
Exceptional Items
-6.41
0.00
-6.41
Gross Profit (PBDT)
199.85
64.75
135.10
208.65%
Depreciation
53.25
10.29
42.96
417.49%
Profit Before Tax
148.05
54.74
93.31
170.46%
Tax
18.77
9.41
9.36
99.47%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
127.83
45.05
82.78
183.75%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
127.83
45.05
82.78
183.75%
Share in Profit of Associates
1.45
0.28
1.17
417.86%
Minority Interest
2.34
0.00
2.34
Other related items
0.00
0.00
0.00
Consolidated Net Profit
126.94
45.33
81.61
180.04%
Equity Capital
92.17
61.61
30.56
49.60%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
13.77
7.36
6.41
87.09%
Diluted Earnings per share
13.77
7.41
6.36
85.83%
Operating Profit Margin (Excl OI)
18.11%
17.56%
0.00
0.55%
Gross Profit Margin
15.10%
18.34%
0.00
-3.24%
PAT Margin
9.77%
12.84%
0.00
-3.07%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,323.47 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 10.78% vs -2.14% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 11.18% vs 14.08% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 126.94 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -37.19% vs 58.48% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 54.45% vs 352.09% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 239.71 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 1.59% vs 1.90% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 10.03% vs 6.63% in Mar 2025
Quarterly - Interest
Interest 41.58 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -4.15% vs -5.96% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -17.37% vs -29.23% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.11%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
